Cite
[GEM plus CDDP Combination Therapy for Unresectable Biliary Tract Cancer-A Single Institution Experience].
MLA
Muneta, Masato, et al. “[GEM plus CDDP Combination Therapy for Unresectable Biliary Tract Cancer-A Single Institution Experience].” Gan to Kagaku Ryoho. Cancer & Chemotherapy, vol. 50, no. 2, Feb. 2023, pp. 239–41. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=36807184&authtype=sso&custid=ns315887.
APA
Muneta, M., Ohmura, Y., Takeda, Y., Katsura, Y., Shinke, G., Kinoshita, M., Aoyama, S., Kihara, Y., Katsuyama, S., Ikeshima, R., Hiraki, M., Sugimura, K., Masuzawa, T., Hata, T., & Murata, K. (2023). [GEM plus CDDP Combination Therapy for Unresectable Biliary Tract Cancer-A Single Institution Experience]. Gan to Kagaku Ryoho. Cancer & Chemotherapy, 50(2), 239–241.
Chicago
Muneta, Masato, Yoshiaki Ohmura, Yutaka Takeda, Yoshiteru Katsura, Go Shinke, Mitsuru Kinoshita, Shu Aoyama, et al. 2023. “[GEM plus CDDP Combination Therapy for Unresectable Biliary Tract Cancer-A Single Institution Experience].” Gan to Kagaku Ryoho. Cancer & Chemotherapy 50 (2): 239–41. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=36807184&authtype=sso&custid=ns315887.